EN
|
LT
| Trade mark | ||
|---|---|---|
| (210) | Application number | 2001 0371 |
| (220) | Date of filing the application | 2001-03-02 |
| (111) | Registration number | 44428 |
| (151) | Registration date | 2001-12-14 |
| (181) | Expire | 2031-03-02 |
| (450) | Date of registration publication, bulletin No. | 2002-01-25, 2002/1 |
| Legal status |
Registered
|
|
| Reproduction of the mark | ||
| (540) | NEULASTIM | |
| (531) | Indication of Vienna Classification | |
| Indication concerning colors claimed | ||
| (591) | ||
| Indication of International Classification of Goods and Services, list of goods and (or) services | ||
| (511) |
5 farmaciniai preparatai, tarp jų farmaciniai preparatai, skatinantys baltųjų kraujo kūnelių gamybą. |
|
| Applicant (731) / Owner (732) | ||
| (732) | Name | AMGEN INC |
| Address | One Amgen Center Drive, Thousand Oaks, CA 91320-1799 | |
| Country | US | |
| Attorney or representative | ||
| (740) | Name | Vitalija Banaitienė |
| Address | UAB "Tarpinė", p.d. 1202 LT-01007, A. P. Kavoliuko g. 24-152, LT-04328 Vilnius | |
| Country | LT | |
| Disclaimer | ||
| (526) | ||
| Exhibition priority | ||
| (230) | Date, country | |
| Convention priority | ||
| (300) | Convention priority | |
| Date | ||
| Country | ||